Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shih

Showing results (891-900 of 925) with videos related to

Pageof 93
Sort By:
Medicine|November 26, 2019
Exophthalmometry values in the Hong Kong Chinese adult population from a population-based studyJanice J C Cheung, Dulcia L Chang, Jonathan C Chan, et al.
Cancer|July 17, 2015
A phase I dose-escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC-223 in patients with advanced solid tumors or multiple myelomaJohanna C Bendell, Robin K Kelley, Kent C Shih, et al.
Translational Oncology|October 17, 2020
BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapyYun-Yu Chen, Chen-Fu Lo, Tai-Yu Chiu, et al.
Neuropharmacology|February 5, 2019
Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT<sub>2A</sub> receptor activationSean C Godar, Laura J Mosher, Simona Scheggi, et al.
Journal for Immunotherapy of Cancer|May 17, 2020
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trialSandra P D'Angelo, Shailender Bhatia, Andrew S Brohl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN LossJohann S de Bono, Ugo De Giorgi, Daniel Nava Rodrigues, et al.
Nature Medicine|December 28, 2004
Tissue-print and print-phoresis as platform technologies for the molecular analysis of human surgical specimens: mapping tumor invasion of the prostate capsuleSandra M Gaston, Marc A Soares, M Minhaj Siddiqui, et al.
JMIR Aging|October 25, 2024
Assessment of Wearable Device Adherence for Monitoring Physical Activity in Older Adults: Pilot Cohort StudyHuitong Ding, Kristi Ho, Edward Searls, et al.
The Lancet. Oncology|September 6, 2016
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trialHoward L Kaufman, Jeffery Russell, Omid Hamid, et al.
Neuro-Oncology|July 29, 2025
Intra-tumoral Preservation of the Stem-like Malignant Cell Proportion in Glioblastoma, Prognostic Impact, and its Radiomethylomic SignaturesYuji Matsumoto, Omkar Singh, Jose Garcia, et al.
Pageof 93

Showing results (891-900 of 925) with videos related to

Sort By:
Pageof 93
Medicine|November 26, 2019
Exophthalmometry values in the Hong Kong Chinese adult population from a population-based studyJanice J C Cheung, Dulcia L Chang, Jonathan C Chan, et al.
Cancer|July 17, 2015
A phase I dose-escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC-223 in patients with advanced solid tumors or multiple myelomaJohanna C Bendell, Robin K Kelley, Kent C Shih, et al.
Translational Oncology|October 17, 2020
BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapyYun-Yu Chen, Chen-Fu Lo, Tai-Yu Chiu, et al.
Neuropharmacology|February 5, 2019
Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT<sub>2A</sub> receptor activationSean C Godar, Laura J Mosher, Simona Scheggi, et al.
Journal for Immunotherapy of Cancer|May 17, 2020
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trialSandra P D'Angelo, Shailender Bhatia, Andrew S Brohl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN LossJohann S de Bono, Ugo De Giorgi, Daniel Nava Rodrigues, et al.
Nature Medicine|December 28, 2004
Tissue-print and print-phoresis as platform technologies for the molecular analysis of human surgical specimens: mapping tumor invasion of the prostate capsuleSandra M Gaston, Marc A Soares, M Minhaj Siddiqui, et al.
JMIR Aging|October 25, 2024
Assessment of Wearable Device Adherence for Monitoring Physical Activity in Older Adults: Pilot Cohort StudyHuitong Ding, Kristi Ho, Edward Searls, et al.
The Lancet. Oncology|September 6, 2016
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trialHoward L Kaufman, Jeffery Russell, Omid Hamid, et al.
Neuro-Oncology|July 29, 2025
Intra-tumoral Preservation of the Stem-like Malignant Cell Proportion in Glioblastoma, Prognostic Impact, and its Radiomethylomic SignaturesYuji Matsumoto, Omkar Singh, Jose Garcia, et al.
Pageof 93